Ra-Capital-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ASND",
  "EWTX",
  "INSM",
  "NAMS",
  "CBLL",
  "ACHC",
  "RXST",
  "BCAX",
  "BCYC",
  "ATXS",
  "RCUS",
  "GPCR",
  "IMTX",
  "SCLX",
  "TVTX",
  "TSHA",
  "TRML",
  "TYRA",
  "LENZ",
  "ACET",
  "NRIX",
  "ACRV",
  "LRMR",
  "MLYS",
  "ABOS",
  "ALEC",
  "AVTX",
  "JANX",
  "ARTV",
  "BIOA",
  null,
  null,
  "GERN",
  "SRRK",
  "FULC",
  "APGE",
  "LXEO",
  null,
  "MNPR",
  "NKTX",
  "SEPN",
  "SRZN",
  "STRO",
  "GHRS",
  "TARA",
  "ACRS",
  "TXG",
  "IDYA",
  "ZURA",
  "SPRY",
  null,
  null,
  "SERA",
  "PEPG",
  "RNA",
  "MBX",
  null,
  "SLDB",
  "FDMT",
  "RYTM",
  "ACLX",
  "ETNB",
  "DYN",
  "BOLD",
  null,
  "GKOS",
  "HUMA",
  "WVE",
  null,
  "CDTX",
  "ELDN",
  "ELVN",
  "EYPT",
  "ITOS",
  "KURA",
  "URGN",
  "VOR",
  "HOWL",
  "ZLAB",
  "XNCR",
  "PCVX",
  "DAWN",
  "CTMX",
  "DNTH",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 85
Total Value: 5952606666
Accession Number: 0001104659-25-049549
Form Type: 13F-HR
CIK: ra-capital-management-lp
Manager Name: Ra-Capital-Management-Lp

Data Enrichment

91% identified

77 identified8 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

85 positions • $6.0B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 5

Sort by:

GH Research PLC

GHRS|G3855L106

Shares:6.9M

Value:$76.6M

% of Portfolio:1.3% ($76.6M/$6.0B)

Apogee Therapeutics, Inc.

APGE|03770N101

Shares:1.6M

Value:$58.6M

% of Portfolio:1.0% ($58.6M/$6.0B)

Dianthus Therapeutics, Inc. /DE/

DNTH|252828108

Shares:2.9M

Value:$52.0M

% of Portfolio:0.9% ($52.0M/$6.0B)

Zai Lab Ltd

ZLAB|98887Q104

Shares:1.3M

Value:$46.8M

% of Portfolio:0.8% ($46.8M/$6.0B)

Day One Biopharmaceuticals, Inc.

DAWN|23954D109

Shares:5.8M

Value:$45.6M

% of Portfolio:0.8% ($45.6M/$6.0B)

Septerna, Inc.

SEPN|81734D104

Shares:7.0M

Value:$40.5M

% of Portfolio:0.7% ($40.5M/$6.0B)

Tourmaline Bio, Inc.

TRML|89157D105

Shares:2.5M

Value:$38.6M

% of Portfolio:0.6% ($38.6M/$6.0B)

Scholar Rock Holding Corp

SRRK|80706P103

Shares:1.1M

Value:$36.5M

% of Portfolio:0.6% ($36.5M/$6.0B)

UroGen Pharma Ltd.

URGN|M96088105

Shares:3.2M

Value:$35.5M

% of Portfolio:0.6% ($35.5M/$6.0B)

Artiva Biotherapeutics, Inc.

ARTV|04317A107

Shares:9.9M

Value:$29.6M

% of Portfolio:0.5% ($29.6M/$6.0B)

Fulcrum Therapeutics, Inc.

FULC|359616109

Shares:10.2M

Value:$29.5M

% of Portfolio:0.5% ($29.5M/$6.0B)

Vor Biopharma Inc.

VOR|929033108

Shares:39.6M

Value:$28.4M

% of Portfolio:0.5% ($28.4M/$6.0B)

Astria Therapeutics, Inc.

ATXS|04635X102

Shares:5.1M

Value:$27.3M

% of Portfolio:0.5% ($27.3M/$6.0B)

Kura Oncology, Inc.

KURA|50127T109

Shares:4.0M

Value:$26.4M

% of Portfolio:0.4% ($26.4M/$6.0B)

Structure Therapeutics Inc.

GPCR|86366E106

Shares:1.5M

Value:$26.3M

% of Portfolio:0.4% ($26.3M/$6.0B)

Cidara Therapeutics, Inc.

CDTX|171757206

Shares:1.1M

Value:$23.5M

% of Portfolio:0.4% ($23.5M/$6.0B)

008064107

Shares:9.2M

Value:$23.1M

% of Portfolio:0.4% ($23.1M/$6.0B)

IDEAYA Biosciences, Inc.

IDYA|45166A102

Shares:1.3M

Value:$22.1M

% of Portfolio:0.4% ($22.1M/$6.0B)

iTeos Therapeutics, Inc.

ITOS|46565G104

Shares:3.6M

Value:$21.8M

% of Portfolio:0.4% ($21.8M/$6.0B)

Travere Therapeutics, Inc.

TVTX|89422G107

Shares:1.1M

Value:$20.6M

% of Portfolio:0.3% ($20.6M/$6.0B)

Instrument	Shares		Other Manager	Value	% of Portfolio
GH Research PLC(GHRScusipG3855L106)	6.9M	QoQ +3.85% (+258.0K) YoY NEW(+6.9M)	All Managers (Combined)	$76.6M	1.3% ($76.6M/$6.0B)	QoQ +63.65% (+$29.8M) YoY NEW(+$76.6M)
Apogee Therapeutics, Inc.(APGEcusip03770N101)	1.6M	QoQ 0.00% (-0) YoY NEW(+1.6M)	All Managers (Combined)	$58.6M	1.0% ($58.6M/$6.0B)	QoQ -17.52% (-$12.5M) YoY NEW(+$58.6M)
Dianthus Therapeutics, Inc. /DE/(DNTHcusip252828108)	2.9M	QoQ +53.59% (+1.0M) YoY NEW(+2.9M)	All Managers (Combined)	$52.0M	0.9% ($52.0M/$6.0B)	QoQ +27.80% (+$11.3M) YoY NEW(+$52.0M)
Zai Lab Ltd(ZLABcusip98887Q104)	1.3M	QoQ 0.00% (+0) YoY NEW(+1.3M)	All Managers (Combined)	$46.8M	0.8% ($46.8M/$6.0B)	QoQ +37.99% (+$12.9M) YoY NEW(+$46.8M)
Day One Biopharmaceuticals, Inc.(DAWNcusip23954D109)	5.8M	QoQ 0.00% (-0) YoY NEW(+5.8M)	All Managers (Combined)	$45.6M	0.8% ($45.6M/$6.0B)	QoQ -37.41% (-$27.3M) YoY NEW(+$45.6M)
Septerna, Inc.(SEPNcusip81734D104)	7.0M	QoQ 0.00% (-0) YoY NEW(+7.0M)	All Managers (Combined)	$40.5M	0.7% ($40.5M/$6.0B)	QoQ -74.71% (-$119.7M) YoY NEW(+$40.5M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	2.5M	QoQ 0.00% (-0) YoY NEW(+2.5M)	All Managers (Combined)	$38.6M	0.6% ($38.6M/$6.0B)	QoQ -25.00% (-$12.9M) YoY NEW(+$38.6M)
Scholar Rock Holding Corp(SRRKcusip80706P103)	1.1M	QoQ +6351.25% (+1.1M) YoY NEW(+1.1M)	All Managers (Combined)	$36.5M	0.6% ($36.5M/$6.0B)	QoQ +4698.88% (+$35.8M) YoY NEW(+$36.5M)
UroGen Pharma Ltd.(URGNcusipM96088105)	3.2M	QoQ NEW(+3.2M) YoY NEW(+3.2M)	All Managers (Combined)	$35.5M	0.6% ($35.5M/$6.0B)	QoQ NEW(+$35.5M) YoY NEW(+$35.5M)
Artiva Biotherapeutics, Inc.(ARTVcusip04317A107)	9.9M	QoQ 0.00% (-0) YoY NEW(+9.9M)	All Managers (Combined)	$29.6M	0.5% ($29.6M/$6.0B)	QoQ -70.23% (-$69.8M) YoY NEW(+$29.6M)
Fulcrum Therapeutics, Inc.(FULCcusip359616109)	10.2M	QoQ 0.00% (-0) YoY NEW(+10.2M)	All Managers (Combined)	$29.5M	0.5% ($29.5M/$6.0B)	QoQ -38.72% (-$18.6M) YoY NEW(+$29.5M)
Vor Biopharma Inc.(VORcusip929033108)	39.6M	QoQ 0.00% (-0) YoY NEW(+39.6M)	All Managers (Combined)	$28.4M	0.5% ($28.4M/$6.0B)	QoQ -35.36% (-$15.6M) YoY NEW(+$28.4M)
Astria Therapeutics, Inc.(ATXScusip04635X102)	5.1M	QoQ 0.00% (-0) YoY NEW(+5.1M)	All Managers (Combined)	$27.3M	0.5% ($27.3M/$6.0B)	QoQ -40.26% (-$18.4M) YoY NEW(+$27.3M)
Kura Oncology, Inc.(KURAcusip50127T109)	4.0M	QoQ -10.02% (-446.4K) YoY NEW(+4.0M)	All Managers (Combined)	$26.4M	0.4% ($26.4M/$6.0B)	QoQ -31.82% (-$12.3M) YoY NEW(+$26.4M)
Structure Therapeutics Inc.(GPCRcusip86366E106)	1.5M	QoQ 0.00% (-0) YoY NEW(+1.5M)	All Managers (Combined)	$26.3M	0.4% ($26.3M/$6.0B)	QoQ -36.17% (-$14.9M) YoY NEW(+$26.3M)
Cidara Therapeutics, Inc.(CDTXcusip171757206)	1.1M	QoQ 0.00% (-0) YoY NEW(+1.1M)	All Managers (Combined)	$23.5M	0.4% ($23.5M/$6.0B)	QoQ -19.86% (-$5.8M) YoY NEW(+$23.5M)
(cusip008064107)✕	9.2M	QoQ 0.00% (-0) YoY NEW(+9.2M)	All Managers (Combined)	$23.1M	0.4% ($23.1M/$6.0B)	QoQ -5.28% (-$1.3M) YoY NEW(+$23.1M)
IDEAYA Biosciences, Inc.(IDYAcusip45166A102)	1.3M	QoQ 0.00% (-0) YoY NEW(+1.3M)	All Managers (Combined)	$22.1M	0.4% ($22.1M/$6.0B)	QoQ -36.26% (-$12.6M) YoY NEW(+$22.1M)
iTeos Therapeutics, Inc.(ITOScusip46565G104)	3.6M	QoQ +74.40% (+1.6M) YoY NEW(+3.6M)	All Managers (Combined)	$21.8M	0.4% ($21.8M/$6.0B)	QoQ +35.57% (+$5.7M) YoY NEW(+$21.8M)
Travere Therapeutics, Inc.(TVTXcusip89422G107)	1.1M	QoQ 0.00% (+0) YoY NEW(+1.1M)	All Managers (Combined)	$20.6M	0.3% ($20.6M/$6.0B)	QoQ +2.87% (+$575.0K) YoY NEW(+$20.6M)